Document Detail


Serum IGF-1 in treated acromegaly - how normal is "normal"?
MedLine Citation:
PMID:  16379035     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We describe four acromegalic patients with persisting typical symptoms - excessive sweating, lack of suppleness of hands, joint pains - despite the achievement of normal serum IGF-1 levels after pituitary surgery. In three patients there was a clear improvement in symptoms when lower IGF-1 levels within the normal range were achieved with pegvisomant treatment. In the fourth patient IGF-1 levels have fluctuated within the normal range with persistence of abnormal sweating, particularly at night. Two of three patients who had an oral glucose tolerance test when serum IGF-1 was in the normal range failed to suppress GH levels to less than 1 ng/ml. We conclude that, in the treated acromegalic patient, IGF-1 levels within the normal range need to be looked at critically to determine what is truly normal for that individual. Relief of symptoms seems a reasonable yardstick, in addition to population norms, by which to judge whether the prevailing IGF-1 level is appropriate; in some cases the aim should be an IGF-1 level in the lower half of the normal range, or perhaps even the lowest quartile.
Authors:
Cecilia Lansang; Nikoloz Chitaia; Nicholas E Simpson; Laurence Kennedy
Related Documents :
12393025 - Clinical significance of the changes of platelet counts and serum thrombopoietin levels...
2720985 - Lactate dehydrogenase isoenzyme patterns in serum of patients with metastatic liver dis...
4102485 - Serum concentration of 19 serum proteins in crohn's disease and ulcerative colitis.
8127215 - Serum lactoferrin in lepromatous leprosy patients.
23970385 - Head and neck presentations of b-nhl and b-al in children/adolescents: experience of th...
21439645 - Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diab...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pituitary     Volume:  8     ISSN:  1386-341X     ISO Abbreviation:  Pituitary     Publication Date:  2005  
Date Detail:
Created Date:  2006-02-27     Completed Date:  2006-06-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9814578     Medline TA:  Pituitary     Country:  United States    
Other Details:
Languages:  eng     Pagination:  135-8     Citation Subset:  IM    
Affiliation:
Division of Endocrinology, Department of Medicine, University of Florida, Gainesville, FL 32610-0226, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acromegaly / blood*,  therapy
Adult
Female
Human Growth Hormone / analogs & derivatives,  therapeutic use
Humans
Insulin-Like Growth Factor I / analysis*
Male
Middle Aged
Reference Values
Chemical
Reg. No./Substance:
0/pegvisomant; 12629-01-5/Human Growth Hormone; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease.
Next Document:  Clinical and molecular features of a TSH-secreting pituitary microadenoma.